[{"from": "human", "value": "Provide a brief overview of this molecule. [C][=C][C][=C][Branch2][Ring1][Branch2][C][=Branch1][Ring2][=C][Ring1][=Branch1][C@H1][Branch1][=Branch2][C][N][N][=C][N][=N][Ring1][Branch1][O][C][=Branch1][C][=O][N][Cl]"}, {"from": "gpt", "value": "The molecule is an antiepileptic drug developed by SK Pharmaceuticals and used to treat partial onset seizures. The exact mechanism of action has not been described in the literature, though it positively modulates GABAA and inhibits voltage gated sodium channels.  Cenobamate was granted FDA approval on 21 November 2019."}]